• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

The Femtech Word of the Year: Momentum

By Kathrin Folkendt Ecosystem, News, Trend Watch January 24, 2024
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Fertility, Investment, News, Reproductive Health December 6, 2022
Virtual Fertility Clinic Turtle Health Launches in 8 US States with $5.4M in Funding
Exit, News, Reproductive Health, Uncategorized August 17, 2021
BioReference Laboratories Acquires the U.S. Ariosa Centralized Lab Prenatal Testing Business from Roche
Written By
Kathrin Folkendt

Kathrin Folkendt is the Founder & CEO of Femtech Insider, the globally leading publication on all things femtech. She usually writes about women's health innovation, health equity, and entrepreneurship.

Recent Posts
  • BlueWind Medical Raises $47.8M to Commercialize Implantable Neuromodulation Device for Urgency Urinary Incontinence
  • Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor
  • UroMems Raises $60M for Smart Implant to Treat Stress Urinary Incontinence
  • Autoimmunity BioSolutions Closes $1M Seed Extension for Genetically Targeted Autoimmune Therapy
  • The Cost Problem: Who Actually Gets to Benefit From Women’s Health Innovation?

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.